| TRADING CENTER |
| Thomson, AuthenTec: Early Volume Plays - at TheStreet.com | |
| Incyte Licenses Drug to Eli Lilly - at TheStreet.com | |
| Pfizer Licenses Athersys Stem Cell Drug: BioBuzz - at TheStreet.com | |
| Swine Flu Just Isn't Bringing Home the Bacon - MotleyFool.com | |
| BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors - PR Newswire | |
| Fearful Stocks for Greedy Investors - MotleyFool.com | |
| US health officials to review disaster plan - Reuters |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.22 | 0.49 / 0.86% | 10.94 |
| GILD | Gilead Sciences Inc | 43.24 | 0.08 / 0.19% | 16.69 |
| CELG | Celgene Corporation | 56.29 | 0.20 / 0.36% | 67.82 |
| 2008 Revenue: | $56.6 M | Headquarters: Birmingham, AL |
| Employees: | 80 | CEO: Jon P. Stonehouse |
| Net Income: | $-24,731,570.0 | Industry: Biotechnology |
| Market Cap: | $228.3 M | Website: www.biocryst.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| BCRX | 6.02 | +0.14 / +2.38% | 5.88 | 6.05 | 5.75 | Profile Chart News |